These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9166297)

  • 1. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Obstet Gynecol; 1997 May; 89(5 Pt 1):666-70. PubMed ID: 9166297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein.
    Roque H
    Obstet Gynecol; 1997 Sep; 90(3):480-1. PubMed ID: 9277668
    [No Abstract]   [Full Text] [Related]  

  • 6. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
    Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
    Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
    Lepage N; Chitayat D; Kingdom J; Huang T
    Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M
    Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
    Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
    Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
    Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
    Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
    Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
    Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
    Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.
    Chen Y; Dai X; Wu B; Jiang C; Yin Y
    BMC Womens Health; 2024 Jun; 24(1):323. PubMed ID: 38835013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased maternal serum hCG levels with increasing gravidity and parity.
    Mooney RA; Arvan DA; Saller DN; French CA; Peterson CJ
    Obstet Gynecol; 1995 Dec; 86(6):900-5. PubMed ID: 7501336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
    Shenhav S; Gemer O; Sassoon E; Volodarsky M; Peled R; Segal S
    Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
    Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
    Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.